Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin
Clinical trial NCT05487781 · UNKNOWN
Trial details
- NCT number
- NCT05487781
- Sponsor
- Molecule X LLC
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2022-06-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.